Modera Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History

Modera Wealth Management’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,300	Closed	-$9.1K	–	564
2023 Q1	$9.1K	Hold	1,300	–	–	﹤0.01%	359
2022 Q4	$9.18K	Hold	1,300	–	–	﹤0.01%	348
2022 Q3	$20K	Hold	1,300	–	–	﹤0.01%	312
2022 Q2	$13K	Hold	1,300	–	–	﹤0.01%	332
2022 Q1	$19K	Hold	1,300	–	–	﹤0.01%	351
2021 Q4	$68K	Hold	1,300	–	–	﹤0.01%	593
2021 Q3	$76K	Sell	1,300 -35	-3%	-$2.28K	﹤0.01%	272
2021 Q2	$108K	Hold	1,335	–	–	0.01%	240
2021 Q1	$111K	Hold	1,335	–	–	0.01%	225
2020 Q4	$102K	Buy	+1,335	New	+$120K	0.01%	235

Other funds holding AXDX

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Modera Wealth Management's AXDX Position: Q2 2023 in Review

Modera Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 1,300 shares — an estimated $9.1K sold.

Modera Wealth Management first reported a position in AXDX in Q4 2020 and held it in 10 quarters. The position peaked at $111K in Q1 2021. 51 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

Modera Wealth Management reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
Modera Wealth Management sold 1,300 Accelerate Diagnostics shares in Q2 2023, an estimated $9.1K.
Modera Wealth Management first reported a position in Accelerate Diagnostics in Q4 2020 and held it in 10 quarters.
Modera Wealth Management's Accelerate Diagnostics position peaked at $111K in Q1 2021.
51 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on Modera Wealth Management's 13F filing for Q2 2023, filed 7 Aug 2023.